Greiner Bio-One Microplates in Space

While fluorescence polarization experiments are commonly performed by pharmaceuticalcompanies for R&D in drug discovery, the Micro-gRx space initiative is a landmark in that thistype of experiment has never been conducted in microgravity and will be the first of its kind tooccur on the ISS. Microplate fluorescence measurements of proteins bound in solution takenwithin the Molecular Devices Spectramax M5 multimode reader aboard the ISS will becompared with those obtained in parallel on Earth. The molecular pharmacology study willprovide insight as to how drugs work on a molecular level in microgravity, paving the way forfuture, even more complex investigations.Greiner Bio-One is excited to supply microplates for Micro-gRx’s research in order to ultimatelyfurther human health, as well as to benefit the international scientific and local Floridacommunities.Weather permitting, the space launch for the Micro-gRx study is currently scheduled forSaturday, September 20, 2014, at 2:16 a.m. EDT. Further information may be found athttp://micro-grx.com/ or on twitter @micro_gRx and @PlatesInSpace.